Robert Torray
Torray Fund
Torray Fund Portfolio 13F
Torray Fund Holdings Activity
- Portfolio value:
- $284.88M≈ (-$18M≈)
- Previous value:
- $303.23M≈
- # of changes:
- 14
- New positions:
- 1
- Reported for:
- 30 Sep 2022 (Q3)
- Latest filing date:
- 21 Nov 2022
Torray Fund has disclosed a total of 14 changes to the portfolio in the (2022 Q3) SEC report(s): increased the number of shares of 6, bought 1 totally new, decreased the number of shares of 4 and completely sold out 3 position(s).
What stocks did Torray Fund buy in 2022 Q3?
During 2022 Q3 Torray Fund has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (TROW) T. Rowe Price Group Inc (added shares +60.05%), (GOOGL) Alphabet Inc, CL-A (added shares +63.85%), (GM) General Motors Company (added shares +25.50%), (BAC) Bank of America Corp (added shares +23.54%) and (EOG) EOG Resources Inc (added shares +23.91%).
What did Torray Fund invest in during 2022 Q3?
14 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Qualcomm Incorporated
|
new
|
+72,125
|
72,125
|
+2.86%
|
$112.98
|
+31.22%($148.26)
|
2.86%
|
2022 Q3
|
≈ 0.25 years
|
|
|
|
Alphabet Inc, CL-A
|
+63.85%
|
+56,050
|
143,830
|
+1.88%
|
$95.65
|
+284.84%($368.10)
|
4.83%
|
2021 Q3
|
≈ 1.25 years
|
|
|
|
T. Rowe Price Group Inc
|
+60.05%
|
+51,710
|
137,823
|
+1.91%
|
$105.01
|
+7.33%($112.71)
|
5.08%
|
2021 Q4
|
≈ 1.00 year
|
|
|
|
Schlumberger NV
|
+27.25%
|
+56,559
|
264,128
|
+0.71%
|
$35.90
|
+37.21%($49.26)
|
3.33%
|
2021 Q1
|
≈ 1.75 years
|
|
|
|
General Motors Company
|
+25.50%
|
+81,000
|
398,630
|
+0.91%
|
$32.09
|
+176.49%($88.73)
|
4.49%
|
2021 Q4
|
≈ 1.00 year
|
|
|
|
EOG Resources Inc
|
+23.91%
|
+16,588
|
85,958
|
+0.65%
|
$111.73
|
+31.24%($146.63)
|
3.37%
|
2021 Q3
|
≈ 1.25 years
|
|
|
|
Bank of America Corp
|
+23.54%
|
+63,324
|
332,340
|
+0.67%
|
$30.20
|
+105.61%($62.10)
|
3.52%
|
2020 Q1
|
≈ 2.75 years
|
|
|
|
JPMorgan Chase & Co
|
-0.36%
|
-299
|
81,910
|
-0.01%
|
$104.50
|
+237.80%($353.00)
|
3.00%
|
2020 Q1
|
≈ 2.75 years
|
|
|
|
Bristol-Myers Squibb Company
|
-14.33%
|
-26,346
|
157,493
|
-0.62%
|
$71.09
|
-9.70%($64.20)
|
3.93%
|
2020 Q1
|
≈ 2.75 years
|
|
|
|
Genuine Parts Co
|
-15.20%
|
-13,047
|
72,810
|
-0.64%
|
$149.32
|
-14.05%($128.34)
|
3.82%
|
2020 Q4
|
≈ 2.00 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.